Home / News Update  / Erba Transasia wins CII MedTech Quality Excellence Award 2025 inLarge Enterprise Category

Erba Transasia wins CII MedTech Quality Excellence Award 2025 inLarge Enterprise Category

Visakhapatnam, December 16, 2025: Erba Transasia, a leading global diagnostics and medicaltechnology company and a strong proponent of the Make in India initiative, has been awarded theWinner – Large Enterprise at the CII MedTech Quality

Visakhapatnam, December 16, 2025: Erba Transasia, a leading global diagnostics and medical
technology company and a strong proponent of the Make in India initiative, has been awarded the
Winner – Large Enterprise at the CII MedTech Quality Excellence Awards 2025, powered by the Andhra
Pradesh MedTech Zone (AMTZ).
The award was presented during the 3rd Edition of the World Health Innovation Forum & Global
MedTech Expo 2025, held at AMTZ, Visakhapatnam. This recognition underscores Erba Transasia’s
sustained commitment to quality, reliability, and technological excellence across its comprehensive
portfolio of diagnostic solutions, many of which are designed, developed, and manufactured in India
for both domestic and global markets.
Aligned with the Government of India’s Make in India vision, Erba Transasia has built robust end-toend capabilities spanning state-of-the-art manufacturing facilities in India, supported by a strong global
manufacturing footprint, and advanced R&D centers in India and overseas. These integrated
capabilities enable the company to deliver high-quality, globally benchmarked diagnostic solutions
while strengthening India’s position as a MedTech manufacturing and innovation hub.
This prestigious honour reflects Erba Transasia’s rigorous quality systems, continuous innovation, and
unwavering focus on delivering accurate, accessible, and dependable diagnostics. Each solution is
developed with a singular purpose—to enhance patient care and support clinicians and laboratories
in making timely and informed clinical decisions.
Speaking on the occasion, Mr. Suresh Vazirani, Founder Chairman, Erba Transasia, said,
“This recognition by CII and AMTZ is a strong validation of our quality-first philosophy and the collective
efforts of our teams across manufacturing, R&D, and operations. As a proud Make in India
organization, we are deeply committed to building world-class MedTech solutions from India for the
world.”
Further strengthening its quality and capability ecosystem, Erba Transasia continues to invest in
knowledge and skill development through the Erba Global MedTech University, which focuses on
training, education, and capability building for healthcare professionals, engineers, and partners across
the diagnostics value chain.
As Erba Transasia expands its presence across India and global markets, the company remains focused
on pushing the boundaries of MedTech innovation while upholding the highest standards of quality,
compliance, and patient safety. This award further reinforces its vision of creating a Healthier and
Happier World through reliable diagnostic solutions that improve lives every day.

digital.medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT